New IDEXX Somaticell SCC Test Takes the Guesswork out of Somatic Cell Counts

Numeric results help dairy producers ensure milk quality and overall herd health in real time

WESTBROOK, Maine, February 17, 2015—IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces the launch of the IDEXX Somaticell™ SCC Test, an on-farm test that eliminates the guesswork about somatic cell counts (SCC) in raw cow milk. The new test will be available in the U.S., Canada and Latin America. By using the Somaticell SCC Test, producers can get clear-cut results on-farm in less than 2 minutes, allowing them to make real-time decisions about how to manage SCC levels.

Knowing whether a somatic cell count is low or high gives producers a better understanding of each cow’s health and more options for ensuring milk quality and overall herd health. High somatic cell counts have been linked to declines in production and poor milk quality and can also indicate that roughly one in three cows in a herd may be infected with subclinical mastitis.1,2

“We’re happy to give producers an approach to testing that provides answers on the spot and doesn’t require any capital investment,” says Olivier te Boekhorst, vice president and general manager of IDEXX Livestock, Poultry and Dairy. “Now, between regular DHIA [Dairy Herd Information Association] tests, producers can assess individual cow and bulk tank milk somatic cell counts in real time. That’s information that will help them better manage herd health and overall milk quality.”

The Somaticell SCC Test gives producers the flexibility to test individual or bulk samples, and ready-to-use reagents and materials make the test easy to use. The Somaticell SCC Test is available in the U.S., Canada and Latin America starting on February 18, 2015. For more information or to order, call IDEXX at 1-800-321-0207 or visit idexx.com/somaticell.

About the IDEXX Livestock, Poultry and Dairy division
Livestock and poultry producers, laboratories, veterinarians and dairy processors depend on IDEXX diagnostic technologies to make confident decisions about animal health, disease management and reproductive efficiency, and to ensure consumers have access to safe, healthy food and milk. Reproducibility, reliability and accuracy are three of the reasons why more than 1 billion IDEXX tests—including dairy residue tests and milk-based diagnostics—have been run worldwide since 1985.


About IDEXX Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com

Note Regarding Forward-Looking Statements

This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” and similar words and expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at sec.gov, at various SEC reference facilities in the United States and via the Company’s website at idexx.com).


Contact:

Cliff Young
North American Marketing Manager
IDEXX Livestock, Poultry and Dairy
clifford-young@idexx.com

  1. Philpot WN, Nickerson SC. Mastitis: Counter Attack. Naperville, IL: Babson Bros; 1992.
  2. Harmon RJ. Physiology of mastitis and factors affecting somatic cell counts.
    J Dairy Sci. 1994;77(7):2103–2112.